SANOFI (SNW.DE) Stock Fundamental Analysis
Europe - FRA:SNW - FR0000120578 - Common Stock
85.43 EUR
-0.09 (-0.11%)
SNW gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 53 industry peers in the Pharmaceuticals industry. While SNW has a great profitability rating, there are some minor concerns on its financial health. SNW has a correct valuation and a medium growth rate. Finally SNW also has an excellent dividend rating. These ratings would make SNW suitable for dividend investing!
1. Profitability
1.1 Basic Checks
SNW had positive earnings in the past year.
In the past year SNW had a positive cash flow from operations.
SNW had positive earnings in each of the past 5 years.
In the past 5 years SNW always reported a positive cash flow from operatings.
1.2 Ratios
SNW has a better Return On Assets (11.05%) than 77.36% of its industry peers.
SNW's Return On Equity of 19.73% is fine compared to the rest of the industry. SNW outperforms 69.81% of its industry peers.
SNW's Return On Invested Capital of 13.84% is fine compared to the rest of the industry. SNW outperforms 71.70% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SNW is significantly below the industry average of 14.46%.
The last Return On Invested Capital (13.84%) for SNW is above the 3 year average (7.31%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROIC | 13.84% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
With a decent Profit Margin value of 20.35%, SNW is doing good in the industry, outperforming 79.25% of the companies in the same industry.
SNW's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 23.59%, SNW is doing good in the industry, outperforming 62.26% of the companies in the same industry.
SNW's Operating Margin has improved in the last couple of years.
The Gross Margin of SNW (71.70%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of SNW has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SNW is creating some value.
SNW has about the same amout of shares outstanding than it did 1 year ago.
SNW has about the same amout of shares outstanding than it did 5 years ago.
SNW has a better debt/assets ratio than last year.
2.2 Solvency
SNW has a debt to FCF ratio of 2.21. This is a good value and a sign of high solvency as SNW would need 2.21 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.21, SNW belongs to the top of the industry, outperforming 83.02% of the companies in the same industry.
SNW has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of SNW (0.21) is better than 73.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Altman-Z | N/A |
ROIC/WACC1.8
WACC7.71%
2.3 Liquidity
A Current Ratio of 1.27 indicates that SNW should not have too much problems paying its short term obligations.
The Current ratio of SNW (1.27) is comparable to the rest of the industry.
SNW has a Quick Ratio of 1.27. This is a bad value and indicates that SNW is not financially healthy enough and could expect problems in meeting its short term obligations.
SNW has a Quick ratio (0.94) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 |
3. Growth
3.1 Past
The earnings per share for SNW have decreased by -5.35% in the last year.
SNW shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.10% yearly.
SNW shows a small growth in Revenue. In the last year, the Revenue has grown by 2.56%.
Measured over the past years, SNW shows a small growth in Revenue. The Revenue has been growing by 3.31% on average per year.
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
3.2 Future
The Earnings Per Share is expected to grow by 6.84% on average over the next years.
SNW is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.46% yearly.
EPS Next Y4.12%
EPS Next 2Y6.3%
EPS Next 3Y6.57%
EPS Next 5Y6.84%
Revenue Next Year-0.42%
Revenue Next 2Y3.06%
Revenue Next 3Y4.26%
Revenue Next 5Y4.46%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 11.24 indicates a reasonable valuation of SNW.
Based on the Price/Earnings ratio, SNW is valued cheaply inside the industry as 83.02% of the companies are valued more expensively.
SNW is valuated cheaply when we compare the Price/Earnings ratio to 25.83, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 9.85 indicates a reasonable valuation of SNW.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SNW indicates a rather cheap valuation: SNW is cheaper than 83.02% of the companies listed in the same industry.
SNW is valuated cheaply when we compare the Price/Forward Earnings ratio to 32.68, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.24 | ||
| Fwd PE | 9.85 |
4.2 Price Multiples
SNW's Enterprise Value to EBITDA ratio is in line with the industry average.
SNW's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SNW is cheaper than 62.26% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.67 | ||
| EV/EBITDA | 10.99 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
SNW has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.73
PEG (5Y)2.21
EPS Next 2Y6.3%
EPS Next 3Y6.57%
5. Dividend
5.1 Amount
SNW has a Yearly Dividend Yield of 4.45%, which is a nice return.
SNW's Dividend Yield is rather good when compared to the industry average which is at 2.99. SNW pays more dividend than 88.68% of the companies in the same industry.
SNW's Dividend Yield is rather good when compared to the S&P500 average which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.45% |
5.2 History
The dividend of SNW has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
SNW pays out 34.82% of its income as dividend. This is a sustainable payout ratio.
The dividend of SNW is growing, but earnings are growing more, so the dividend growth is sustainable.
DP34.82%
EPS Next 2Y6.3%
EPS Next 3Y6.57%
FRA:SNW (11/7/2025, 7:00:00 PM)
85.43
-0.09 (-0.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners47.5%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap208.20B
Revenue(TTM)66.91B
Net Income(TTM)13.81B
Analysts81.38
Price Target106.39 (24.53%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.45% |
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)9.77%
Revenue beat(16)9
Avg Revenue beat(16)21.47%
PT rev (1m)-3.34%
PT rev (3m)-4.86%
EPS NQ rev (1m)-3.95%
EPS NQ rev (3m)-8.32%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.92%
Revenue NQ rev (1m)-1.49%
Revenue NQ rev (3m)-2.89%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.93%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.24 | ||
| Fwd PE | 9.85 | ||
| P/S | 3.07 | ||
| P/FCF | 20.67 | ||
| P/OCF | 18.3 | ||
| P/B | 2.97 | ||
| P/tB | 22.4 | ||
| EV/EBITDA | 10.99 |
EPS(TTM)7.6
EY8.9%
EPS(NY)8.68
Fwd EY10.16%
FCF(TTM)4.13
FCFY4.84%
OCF(TTM)4.67
OCFY5.47%
SpS27.86
BVpS28.73
TBVpS3.81
PEG (NY)2.73
PEG (5Y)2.21
Graham Number70.09
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROCE | 16.7% | ||
| ROIC | 13.84% | ||
| ROICexc | 16.48% | ||
| ROICexgc | 66.95% | ||
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% | ||
| FCFM | 14.83% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexgc growth 3Y-13.63%
ROICexgc growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Debt/EBITDA | 0.75 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 58.05% | ||
| Profit Quality | 72.91% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | N/A |
F-Score7
WACC7.71%
ROIC/WACC1.8
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
EPS Next Y4.12%
EPS Next 2Y6.3%
EPS Next 3Y6.57%
EPS Next 5Y6.84%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
Revenue Next Year-0.42%
Revenue Next 2Y3.06%
Revenue Next 3Y4.26%
Revenue Next 5Y4.46%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year30.73%
EBIT Next 3Y13.89%
EBIT Next 5Y9.93%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%
SANOFI / SNW.DE FAQ
Can you provide the ChartMill fundamental rating for SANOFI?
ChartMill assigns a fundamental rating of 6 / 10 to SNW.DE.
Can you provide the valuation status for SANOFI?
ChartMill assigns a valuation rating of 6 / 10 to SANOFI (SNW.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for SANOFI?
SANOFI (SNW.DE) has a profitability rating of 7 / 10.
What is the financial health of SANOFI (SNW.DE) stock?
The financial health rating of SANOFI (SNW.DE) is 5 / 10.
What is the expected EPS growth for SANOFI (SNW.DE) stock?
The Earnings per Share (EPS) of SANOFI (SNW.DE) is expected to grow by 4.12% in the next year.